首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1498612

生物技术市场规模、份额、成长分析，按类型、按产品、按技术、按应用、按地区 - 产业预测，2024-2031 年

Biotechnology Market Size, Share, Growth Analysis, By Type, By Product(Instrument & Reagent ), By Technology, By Application, By Region - Industry Forecast 2024-2031

出版日期: 2024年06月09日 | 出版商:

SkyQuest | 英文 260 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年生物技术市场规模将为1.21兆美元，从2023年的1.38兆美元成长到2031年的3.9兆美元，在预测期间（2024-2031年）预计复合年增长率为13.9%。

美国、中国和印度人口的成长增加了小麦、大米和甘蔗等主食的需求和经济重要性。同时，科学家们正在深入研究水资源短缺、农业生产力和病虫害防治等问题的解决方案，重点是创新技术和合作研究。政府和私营部门的倡议正在增加对生物技术的资助并支持研究和产品开发。随着糖尿病和癌症等慢性疾病在全球范围内变得越来越普遍，预计生物技术领域对先进治疗方法的需求将不断增加，这为专门从事生物技术创新的公司提供了广阔的前景。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

AstraZeneca（UK）
Gilead Sciences, Inc.（US）
Biogen Inc.（US）
Merck（Germany）
Illumina, Inc.（US）
Novo Nordisk A/S（Denmark）
Thermo Fisher Scientific Inc.（US）
Agilent Technologies, Inc.（US）
Lonza Group AG（Switzerland）
Pfizer Inc.（US）
Bristol-Myers Squibb（US）
Amgen Inc.（US）
AbbVie Inc.（US）
Regeneron Pharmaceuticals, Inc.（US）
Vertex Pharmaceuticals Incorporated（US）
Roche Holding AG（Switzerland）
Bio-Rad Laboratories, Inc.（US）
Moderna, Inc.（US）
Qiagen NV（Netherlands）
Johnson & Johnson Services, Inc.（US）

简介目录

Product Code: SQMIG35H2249

Biotechnology Market size was valued at USD 1.21 Trillion in 2022 and is poised to grow from USD 1.38 Trillion in 2023 to USD 3.90 Trillion by 2031, growing at a CAGR of 13.9% during the forecast period (2024-2031).

The biotech industry is globally interconnected and driven by diverse economic growth across nations, with investments expected to rise due to pressing health challenges like hepatitis B. Population growth in the US, China, and India is increasing demand for staple foods such as wheat, rice, and sugarcane, heightening their economic importance. Concurrently, scientists are intensively researching solutions to issues like water scarcity, agricultural productivity, and pest control, focusing on innovative technologies and collaborations. Government and private sector initiatives bolster biotech funding, supporting R&D and product development. As chronic diseases like diabetes and cancer become more prevalent worldwide, the biotech sector anticipates heightened demand for advanced treatments, offering promising prospects for companies specializing in biotech innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biotechnology Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biotechnology Market Segmental Analysis

The biotechnology market is segmented by type, product, technology, application, and region. Based on type the market is segmented into Blue Biotechnology, Green Biotechnology, Red Biotechnology, White Biotechnology, and Others. Based on product the market is segmented into Instrument & Reagent (Clinical Diagnostics, Proteomics and genomics, Drug Discovery & Development, Cell Analysis, Others), Software & Service. Based on technology, the market can be segmented into Nanobiotechnology, PCR Technology, Bioinformatics, Tissue Engineering, DNA sequencing, Fermentation Technology, and others. Based on application, the market is segmented into Health, Agriculture, Food and Beverages, Industrial Processing, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Biotechnology Market

The biotechnology market is currently driven by advancements in cell and tissue development research, expected to fuel its growth in the coming years. A notable example is Bharat Biotech, an Indian pharmaceutical company, which in August 2022 released phase III clinical trial data for their nasal spray COVID-19 vaccine variant, BBV-154. These trials demonstrated the vaccine's safety and tolerability, receiving approval from the Drug Controller General of India (DCGI) for further comparative studies against Covaxin. This development underscores the market's trajectory towards innovative biotechnological solutions, particularly in vaccine development, influencing the industry's expansion and future prospects significantly.

Restraints in the Biotechnology Market

Legend Biotech Corporation, a U.S.-based biotechnology company specializing in innovative therapies, halted a Phase 1 clinical trial for their CAR-T product after determining it did not meet anticipated outcomes, affecting the biotechnology market's momentum. This decision, communicated to the U.S. FDA, underscores challenges in biotech research where trials may not yield expected clinical benefits. Specifically, in July 2022, Legend Biotech terminated its Investigational New Drug (IND) application for L, a CAR-T therapy, due to findings suggesting no significant therapeutic efficacy akin to their CAR-T product LB1901 under trial in China. Such setbacks can impede growth in the biotechnology sector, influencing investor confidence and research strategies moving forward.

Market Trends of the Biotechnology Market

DNA sequencing has become a pivotal force in the market, driven significantly by cost reductions and the incorporation of advanced techniques. The decreasing expenses and the application of sophisticated methodologies have cemented its critical role in both research and diagnostics, contributing to its widespread acceptance and substantial influence on the market landscape. The increasing accessibility of DNA sequencing not only fosters innovation in genetic research but also enhances its utility in clinical settings, thereby fueling its expansion and market prominence.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Case Study Analysis
Pipeline Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Biotechnology Market by Type

Market Overview
Blue Biotechnology
Green Biotechnology
Red Biotechnology
White Biotechnology
Others

Biotechnology Market by Product

Market Overview
Instrument & Reagent
- Clinical Diagnostics
- Proteomics and genomics
- Drug Discovery & Development
- Cell Analysis
- Others
Software & Service

Biotechnology Market by Technology

Market Overview
Nanobiotechnology
PCR Technology
Bioinformatics
Tissue Engineering and Regeneration
Cell-based Assays
DNA sequencing
Fermentation Technology
Chromatography
Others

Biotechnology Market by Application

Market Overview
Health
Agriculture
Food and Beverages
Natural Resources & Environment
Industrial Processing
Others

Biotechnology Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gilead Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regeneron Pharmaceuticals, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vertex Pharmaceuticals Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moderna, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Services, Inc.(US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments